VAERS Explorer
Back to explore

Report #2887994

Received Mar 6, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURER1UNK

Symptoms (4)

Herpes zosterMultiple fracturesPainRash

Symptom narrative

broken bones; shingles/rash/pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of broken bones in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced broken bones (Verbatim: broken bones) (serious criteria GSK medically significant) and shingles (Verbatim: shingles/rash/pain). The outcome of the broken bones and shingles were not reported. It was unknown if the reporter considered the broken bones and shingles to be related to Shingles vaccine. The company considered the broken bones to be unrelated to Shingles vaccine. It was unknown if the company considered the shingles to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 28-FEB-2026 This case was reported by patient via interactive digital media. The patient stated that shingles started on back which looked like spider bite and next 12 hours went to armpit as a rash, then to chest. The patient also stated that it felt like being in vice grip and it was brutal, felt worst pain and had broken bones. The patient was debating the second shot. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Multiple fractures, an unknown time after receiving the 1st dose of Shingles vaccine, in a patient. Based on the available information, a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.